Ciliary Healthcare Profile
Key Indicators
- Authorised Capital ₹ 9.50 M
as on 12-12-2024
- Paid Up Capital ₹ 9.50 M
as on 12-12-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.55 Cr
as on 12-12-2024
- Satisfied Charges ₹ 8.30 Cr
as on 12-12-2024
- Revenue %
(FY 2023)
- Profit 142.72%
(FY 2023)
- Ebitda 6582.35%
(FY 2023)
- Net Worth 90.00%
(FY 2023)
- Total Assets 114.63%
(FY 2023)
About Ciliary Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.50 M and a paid-up capital of Rs 9.50 M.
The company currently has active open charges totaling ₹5.55 Cr. The company has closed loans amounting to ₹8.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Sehgal and Poonam Grover serve as directors at the Company.
- CIN/LLPIN
U24290HP2021PTC008537
- Company No.
008537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ciliary Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Sehgal  | Director | 29-Apr-2021 | Current |
| Poonam Grover | Director | 29-Apr-2021 | Current |
Financial Performance of Ciliary Healthcare.
Ciliary Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 142.72% increase in profit. The company's net worth Soared by an impressive increase of 90%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ciliary Healthcare?
In 2023, Ciliary Healthcare had a public holding of 31.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Choroid Laboratories Private LimitedActive 11 years 2 monthsSaurabh Sehgal and Poonam Grover are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Aug 2024 | ₹2.50 Cr | Open |
Others Creation Date: 01 Aug 2024 | ₹2.50 Cr | Open |
Axis Bank Limited Creation Date: 14 Mar 2024 | ₹5.46 M | Open |
How Many Employees Work at Ciliary Healthcare?
Ciliary Healthcare has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ciliary Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciliary Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
